Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
20594 | JTE-151 | 1404380-58-0 | 98% Min. | |
20534 | JNJ-54175446 | 1627902-21-9 | 98% Min. | |
JNJ-54175446 is a potent and selective P2X7 Receptor Antagonist. JNJ-54175446 is pote | ||||
20495 | JC124 | 1638611-48-9 | 98% Min. | |
JC124 is a NLRP3 Inflammasome Inhibitor. | ||||
20479 | JTE-607 HCl | 188791-09-5 | 98% Min. | |
JTE-607, also known as TO-207, is a cytokine production inhibitor potentially for the | ||||
20458 | JTE-051 | 1309784-09-5 | 98% Min. | |
JTE-051 is a novel inhibitor of interleukin-2-inducible T cell kinase (ITK), suppress | ||||
20285 | JQKD82 | 2410512-38-6 | 98% Min. | |
JQKD82 is a cell-permeable and selective KDM5 inhibitor (MM.1S cells, IC50 = 0.42 uM) | ||||
21250 | JNJ-63576253 | 2110426-27-0 | 98% Min. | |
TRC253, also known as JNJ63576253, is a potent and orally active androgen receptor an | ||||
21247 | JUN90152 | 2098890-15-2 | 98% Min. | |
JUN90152, also known as SMS2-IN-1, is a potent and highly selective sphingomyelin syn | ||||
2091904 | JND3229 | 2260886-64-2 | 98% Min. | |
JND3229 is a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy (IC50 = 5. | ||||
2071624 | JMS-17-2 | 1380392-05-1 | 98% Min. | |
JMS-17-2 is a potent and selective antagonist of CX3CR1. | ||||
2071551 | JAK3-IN-2 | 1443235-95-7 | 98% Min. | |
JAK3-IN-2 is a potent and highly selective JAK3 inhibitor. | ||||
2071526 | JI051 | 2234281-75-3 | 98% Min. | |
JI051 is an inhibitor of the cancer-associated transcription factor Hes1 via the PHB2 | ||||
2071507 | JNJ-632 | 1572510-42-9 | 98% Min. | |
JNJ-632 is a potent HVV capsid assembly modulator and HBV replication inhibitor with | ||||
2061305 | JNK-IN-7 | 1408064-71-0 | 98% Min. | |
JNK-IN-7 is a relatively selective JNKs inhibitor(IC50= 1.54/1.99/0.75 for JNK1/2/3); | ||||
2061305 | JNK-IN-7 | 1408064-71-0 | 98% Min. | |
204307 | JNJ-38877618 | 943540-74-7 | 98% Min. | |
JNJ-38877618 is a hepatocyte growth factor receptor (HGFR; MET; c-Met) inhibitor pote | ||||
193292 | JNJ-64619178 | 2086772-26-9 | >98% | |
JNJ-64619178 is an anticancer drug candidate. | ||||
193201 | JNJ0966 | 315705-75-0 | >98% | |
JNJ0966 is a highly selective allosteric inhibitor of matrix metalloproteinase-9 (MMP | ||||
184313 | JTE-013 | 383150-41-2 | >98% | |
TE-013 is a potent, selective sphingosine-1-phosphate 2 (S1P2) receptor antagonist th | ||||
18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧95.0% | |
JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type ami | ||||
1711221 | JNJ-40346527 | 1142363-52-7 | >98% | |
JNJ-40346527 is a small molecule and orally available inhibitor of colony-stimulating | ||||
1791311 | JNJ-42153605 | 1254977-87-1 | 98.0% | |
JNJ-42153605 is a potent and selective mGlu2 receptor PAM with an acceptable pharmaco | ||||
1783012 | JNJ-42165279(2HCl salt) | 1346528-51-5 | 98.0% | |
JNJ-42165279 exhibited excellent ADME and pharmacodynamic properties as evidenced by | ||||
1783011 | JNJ-42165279(mono HCl salt) | 1346528-52-6 | 98.0% | |
JNJ-42165279 is a potent and selective fatty acid amide hydrolase (FAAH) inhibitor. J | ||||
2017871 | JQ-EZ-05 | 1913252-04-6 | 98.0% | |
JQ-EZ-05, also known as JQEZ5, is a bio active chemical. | ||||
16123027 | JNK-IN-8 | 1410880-22-6 | 98% | |
JNK-IN-8, also known as JNK Inhibitor XVI, is a selective JNK inhibitor that inhibits | ||||
16123026 | JNJ 63533054 | 1802326-66-4 | 98% | |
JNJ 63533054 is a potent and selective GPR139 agonist (EC50 = 16 nM) that is brain an | ||||
16123025 | JNJ-42165279 | 1346528-50-4 | 98% | |
JNJ-42165279 is a potent and selective fatty acid amide hydrolase (FAAH) inhibitor. J | ||||
16122823 | JI-101 | 900573-88-8 | 98% | |
JI-101 is an orally active inhibitor of vascular endothelial growth factor receptor 2 | ||||
6112701 | JPH203 ( KYT-0353 ) | 1037592-40-7 | ≧98.0% | |
JPH203(also known as KYT-0353) is a potent and selective LAT1 selective ( L-type amin |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1